Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06914232
NA

Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES

Sponsor: Superior University

View on ClinicalTrials.gov

Summary

Dry eye disease (DED) is a multifactorial condition often exacerbated by cataract surgery, leading to discomfort and visual disturbances. Meibomian gland dysfunction (MGD), a key cause of DED, contributes to tear film instability, which can be managed with warm compress therapy.

Official title: Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative Dry Eye Syndrome After Cataract Surgery: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

50 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

54

Start Date

2025-03-20

Completion Date

2026-02-20

Last Updated

2025-04-06

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Warm Compress

The intervention involves perioperative Warm compress therapy administered to the participants in the intervention group before and after cataract surgery for 3 seesions per week for 6 weeks. The therapy aims to enhance tear film stability and alleviate symptoms of dry eye by delivering warm compress to the meibomian glands to restore their function. Participants will undergo a session of warm compress therapy prior to surgery and another one following the surgery.

DIAGNOSTIC_TEST

Standard Care

The control group will receive standard care, which includes artificial tears or other conventional methods for dry eye management for 3 sessions per week for 6 weeks. , but they will not receive Warm Compress therapy.

Locations (1)

Hakeem mahmood trust hospital address alam chowk mean baipas

Gujranwala, Punjab Province, Pakistan